Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring

Conditions:   Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2014

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Condition:   Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions:   Drug: Tafamidis;   Drug: Tafamidis;   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified April 2014

AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure

Conditions:   Heart Failure Congestive;   Ischemic Cardiomyopathy;   Non-ischemic Cardiomyopathy
Interventions:   Genetic: MYDICAR-single intracoronary infusion;   Genetic: Placebo; single intracoronary infusion
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Celladon Corporation
Recruiting - verified April 2014

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Other: None - this is an observational study
Sponsors:   University of Virginia;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2014

Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy

Condition:   Dilated Cardiomyopathy
Interventions:   Biological: ucMSC;   Other: Controls
Sponsor:   Universidad Los Andes
Recruiting - verified April 2014

Burden of Illness Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers

Conditions:   Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP);   Transthyretin Cardiomyopathy (TTR-CM);   Familial Amyloid Cardiomyopathy;   Senile Systemic Amyloidosis (SSA)
Interventions:   Other: No drug;   Other: No drug
Sponsor:   Pfizer
Enrolling by invitation - verified April 2014

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy

Condition:   Cardiomegaly
Intervention:   Drug: MEK162
Sponsors:   Novartis;   Novartis Pharmaceuticals
Recruiting - verified April 2014

UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic Implantable Cardiac Defibrillator Implant

Conditions:   Cardiomyopathies;   Cardiac Arrhythmias;   Cardiac Arrest
Sponsor:   Medtronic Bakken Research Center
Recruiting - verified April 2014

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

Conditions:   Acute Myocardial Infarction;   Congestive Heart Failure;   ST-Elevation Myocardial Infarction
Interventions:   Device: Sodium Alginate and Calcium Gluconate;   Device: Saline Solution
Sponsors:   Bellerophon;   Bellerophon BCM, LLC
Recruiting - verified April 2014

The Perceived Impact of Children s Risk Status for Hypertrophic Cardiomyopathy on Families: an Exploratory Study

Condition:   Cardiovascular Disease
Sponsors:   National Institutes of Health Clinical Center (CC);   National Human Genome Research Institute (NHGRI)
Completed - verified March 2014

Spironolactone in Adult Congenital Heart Disease

Conditions:   Congenital Heart Disease;   Heart Failure;   Endomyocardial Fibrosis
Interventions:   Drug: Spironolactone;   Other: Placebo
Sponsors:   Oregon Health and Science University;   National Heart, Lung, and Blood Institute (NHLBI);   Oregon Clinical and Translational Research Institute
Recruiting - verified April 2014

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

Conditions:   Sarcoidosis of the Heart;   Cardiomyopathy
Sponsors:   Virginia Commonwealth University;   Stanford University;   Mount Sinai School of Medicine;   Weill Medical College of Cornell University;   The Cleveland Clinic
Enrolling by invitation - verified April 2014

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Condition:   TTR-CM
Intervention:   Drug: tafamidis
Sponsor:   Pfizer
Active, not recruiting - verified April 2014

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Conditions:   Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention:   Other: None. Observational Study.
Sponsor:   Pfizer
Recruiting - verified April 2014

Get CardioSmart

You're Invited